Soliton Stock: Eagerly Anticipating News from the FDA
Almost two years have passed since I first wrote about the promise of Soliton for tattoo removal. Since then, the company expanded its indications to include cellulite removal. Soliton (SOLY) is currently rallying apparently in anticipation of news from the FDA on the cellulite application. Next, the coronavirus pandemic delayed plans for a 2020 launch. … Read more